Remedy Entertainment Faces Financial Challenges, Plans Accelerated Development of Key Franchises

Despite a revenue drop and operating losses in 2023, Remedy aims for a faster release cadence for Alan Wake and Control sequels, while Max Payne remakes show promise.

Remedy Entertainment faces financial challenges in 2023, with a 22.2% revenue drop and operating losses due to increased investments and a significant impairment charge for Project Kestrel.
Alan Wake 2, despite being critically acclaimed and the fastest-selling game in Remedy's history, has not yet fully recouped its development costs, though it has generated significant revenue.
Remedy plans to accelerate the development of sequels for Alan Wake and Control, aiming for a more regular cadence of releases to boost brand recognition and revenue.
The Max Payne 1 and 2 remakes are fully funded by Rockstar Games and share a similar development budget with Alan Wake 2, indicating high expectations for these projects.
Remedy acquires full rights to the Control franchise, signaling potential new business models and partnerships for future titles, including Control 2 and the multiplayer spin-off Codename Condor.